Rimactazid Plus 600 mg/300 mg Tablet
By Rimactazid Plus
Rx
4 Tablet in a Strip

Composition
Rifampicin(600mg) + Isoniazid(300mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
September, 2025

liver
Rimactazid Plus 600 mg/300 mg Tablet needs to be used carefully in individuals with liver problems. It may be necessary to adjust the dosage of Rimactazid Plus 600 mg/300 mg Tablet in such cases. It is advisable to seek advice from a healthcare professional before its use. For patients with severe liver disease, it is not recommended to use Rimactazid Plus 600 mg/300 mg Tablet.

kidney
Rimactazid Plus 600 mg/300 mg Tablet requires caution if you have kidney disease. Consult your doctor for potential dose adjustments.

alcohol
When taking Rimactazid Plus 600 mg/300 mg Tablet, avoid alcohol to prevent symptoms like flushing, rapid heartbeat, nausea, thirst, chest pain, and low blood pressure (Disulfiram reaction).

driving
Caution - Driving Rimactazid Plus 600 mg/300 mg Tablet may lead to side effects like fits, mental health issues, and optic neuritis, which could impact your driving ability.

pregnancy
Rimactazid Plus 600 mg/300 mg Tablet may be unsafe during pregnancy. Limited human studies and animal studies show harmful effects on the developing baby. Doctor will assess benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Rimactazid Plus 600 mg/300 mg Tablet is considered safe to use while breastfeeding. Studies show the medication does not pass into breastmilk in significant quantities, making it unlikely to harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹64.94
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024